WNT10A and ovarian carcinoma: According to RNA-seq data from various human tumors, WNT10A was highly expressed in lung cancer (2.9 ± 6.7 FPKM), head and neck cancer (7.3 ± 7.6 FPKM), stomach cancer (3.9 ± 7.3 FPKM), pancreatic cancer (4.3 ± 4.9 FPKM), urothelial cancer (4.9 ± 8.0 FPKM), endometrial cancer (3.4 ± 7.1 FPKM), and ovarian cancer (17.7 ± 17.9 FPKM), while the average FPKM of WNT10A in other cancers was less than 1.5 (Figure 9(a)).